世界のヘッジホッグ経路阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hedgehog Pathway Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4292
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ヘッジホッグ経路阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスモデギブ、エリスモデギブ、その他）、用途別市場規模（基底細胞癌（BCC）、急性リンパ芽球性白血病（AML）、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ヘッジホッグ経路阻害剤の市場動向
・企業の競争状況、市場シェア
・ヘッジホッグ経路阻害剤の種類別市場規模と予測2016-2027（ビスモデギブ、エリスモデギブ、その他）
・ヘッジホッグ経路阻害剤の用途別市場規模と予測2016-2027（基底細胞癌（BCC）、急性リンパ芽球性白血病（AML）、その他）
・ヘッジホッグ経路阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・ヘッジホッグ経路阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ヘッジホッグ経路阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ヘッジホッグ経路阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・ヘッジホッグ経路阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、Roche、Mayne Pharma Group、PellePharm、Sun Pharmaceutical）
・結論

Hedgehog pathway inhibitors are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway.

Market Analysis and Insights: Global Hedgehog Pathway Inhibitors Market
The global Hedgehog Pathway Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hedgehog Pathway Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hedgehog Pathway Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hedgehog Pathway Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hedgehog Pathway Inhibitors market.

Global Hedgehog Pathway Inhibitors Scope and Market Size
Hedgehog Pathway Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hedgehog Pathway Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Vismodegib
Erismodegib
Other

Segment by Application
Basal Cell Carcinoma (BCC)
Acute Lymphoblastic Leukemia (AML)
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Roche
Mayne Pharma Group
PellePharm
Sun Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hedgehog Pathway Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vismodegib
1.2.3 Erismodegib
1.2.4 Other
1.3 Market by Application
1.3.1 Global Hedgehog Pathway Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Basal Cell Carcinoma (BCC)
1.3.3 Acute Lymphoblastic Leukemia (AML)
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hedgehog Pathway Inhibitors Market Perspective (2016-2027)
2.2 Hedgehog Pathway Inhibitors Growth Trends by Regions
2.2.1 Hedgehog Pathway Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hedgehog Pathway Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Hedgehog Pathway Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Hedgehog Pathway Inhibitors Industry Dynamic
2.3.1 Hedgehog Pathway Inhibitors Market Trends
2.3.2 Hedgehog Pathway Inhibitors Market Drivers
2.3.3 Hedgehog Pathway Inhibitors Market Challenges
2.3.4 Hedgehog Pathway Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hedgehog Pathway Inhibitors Players by Revenue
3.1.1 Global Top Hedgehog Pathway Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Hedgehog Pathway Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Hedgehog Pathway Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hedgehog Pathway Inhibitors Revenue
3.4 Global Hedgehog Pathway Inhibitors Market Concentration Ratio
3.4.1 Global Hedgehog Pathway Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hedgehog Pathway Inhibitors Revenue in 2020
3.5 Hedgehog Pathway Inhibitors Key Players Head office and Area Served
3.6 Key Players Hedgehog Pathway Inhibitors Product Solution and Service
3.7 Date of Enter into Hedgehog Pathway Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hedgehog Pathway Inhibitors Breakdown Data by Type
4.1 Global Hedgehog Pathway Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Hedgehog Pathway Inhibitors Forecasted Market Size by Type (2022-2027)

5 Hedgehog Pathway Inhibitors Breakdown Data by Application
5.1 Global Hedgehog Pathway Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Hedgehog Pathway Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hedgehog Pathway Inhibitors Market Size (2016-2027)
6.2 North America Hedgehog Pathway Inhibitors Market Size by Type
6.2.1 North America Hedgehog Pathway Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Hedgehog Pathway Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Hedgehog Pathway Inhibitors Market Size by Type (2016-2027)
6.3 North America Hedgehog Pathway Inhibitors Market Size by Application
6.3.1 North America Hedgehog Pathway Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Hedgehog Pathway Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Hedgehog Pathway Inhibitors Market Size by Application (2016-2027)
6.4 North America Hedgehog Pathway Inhibitors Market Size by Country
6.4.1 North America Hedgehog Pathway Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Hedgehog Pathway Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hedgehog Pathway Inhibitors Market Size (2016-2027)
7.2 Europe Hedgehog Pathway Inhibitors Market Size by Type
7.2.1 Europe Hedgehog Pathway Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Hedgehog Pathway Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Hedgehog Pathway Inhibitors Market Size by Type (2016-2027)
7.3 Europe Hedgehog Pathway Inhibitors Market Size by Application
7.3.1 Europe Hedgehog Pathway Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Hedgehog Pathway Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Hedgehog Pathway Inhibitors Market Size by Application (2016-2027)
7.4 Europe Hedgehog Pathway Inhibitors Market Size by Country
7.4.1 Europe Hedgehog Pathway Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Hedgehog Pathway Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hedgehog Pathway Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Type
8.2.1 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Application
8.3.1 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Region
8.4.1 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hedgehog Pathway Inhibitors Market Size (2016-2027)
9.2 Latin America Hedgehog Pathway Inhibitors Market Size by Type
9.2.1 Latin America Hedgehog Pathway Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Hedgehog Pathway Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Hedgehog Pathway Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Hedgehog Pathway Inhibitors Market Size by Application
9.3.1 Latin America Hedgehog Pathway Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Hedgehog Pathway Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Hedgehog Pathway Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Hedgehog Pathway Inhibitors Market Size by Country
9.4.1 Latin America Hedgehog Pathway Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Hedgehog Pathway Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hedgehog Pathway Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Type
10.2.1 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Application
10.3.1 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Country
10.4.1 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hedgehog Pathway Inhibitors Introduction
11.1.4 Pfizer Revenue in Hedgehog Pathway Inhibitors Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Hedgehog Pathway Inhibitors Introduction
11.2.4 Novartis Revenue in Hedgehog Pathway Inhibitors Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Hedgehog Pathway Inhibitors Introduction
11.3.4 Roche Revenue in Hedgehog Pathway Inhibitors Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Mayne Pharma Group
11.4.1 Mayne Pharma Group Company Details
11.4.2 Mayne Pharma Group Business Overview
11.4.3 Mayne Pharma Group Hedgehog Pathway Inhibitors Introduction
11.4.4 Mayne Pharma Group Revenue in Hedgehog Pathway Inhibitors Business (2016-2021)
11.4.5 Mayne Pharma Group Recent Development
11.5 PellePharm
11.5.1 PellePharm Company Details
11.5.2 PellePharm Business Overview
11.5.3 PellePharm Hedgehog Pathway Inhibitors Introduction
11.5.4 PellePharm Revenue in Hedgehog Pathway Inhibitors Business (2016-2021)
11.5.5 PellePharm Recent Development
11.6 Sun Pharmaceutical
11.6.1 Sun Pharmaceutical Company Details
11.6.2 Sun Pharmaceutical Business Overview
11.6.3 Sun Pharmaceutical Hedgehog Pathway Inhibitors Introduction
11.6.4 Sun Pharmaceutical Revenue in Hedgehog Pathway Inhibitors Business (2016-2021)
11.6.5 Sun Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hedgehog Pathway Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vismodegib
Table 3. Key Players of Erismodegib
Table 4. Key Players of Other
Table 5. Global Hedgehog Pathway Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hedgehog Pathway Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hedgehog Pathway Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hedgehog Pathway Inhibitors Market Share by Regions (2016-2021)
Table 9. Global Hedgehog Pathway Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hedgehog Pathway Inhibitors Market Share by Regions (2022-2027)
Table 11. Hedgehog Pathway Inhibitors Market Trends
Table 12. Hedgehog Pathway Inhibitors Market Drivers
Table 13. Hedgehog Pathway Inhibitors Market Challenges
Table 14. Hedgehog Pathway Inhibitors Market Restraints
Table 15. Global Hedgehog Pathway Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hedgehog Pathway Inhibitors Market Share by Players (2016-2021)
Table 17. Global Top Hedgehog Pathway Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hedgehog Pathway Inhibitors as of 2020)
Table 18. Ranking of Global Top Hedgehog Pathway Inhibitors Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hedgehog Pathway Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hedgehog Pathway Inhibitors Product Solution and Service
Table 22. Date of Enter into Hedgehog Pathway Inhibitors Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hedgehog Pathway Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hedgehog Pathway Inhibitors Revenue Market Share by Type (2016-2021)
Table 26. Global Hedgehog Pathway Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hedgehog Pathway Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hedgehog Pathway Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hedgehog Pathway Inhibitors Revenue Market Share by Application (2016-2021)
Table 30. Global Hedgehog Pathway Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hedgehog Pathway Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hedgehog Pathway Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hedgehog Pathway Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hedgehog Pathway Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hedgehog Pathway Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hedgehog Pathway Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hedgehog Pathway Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hedgehog Pathway Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hedgehog Pathway Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hedgehog Pathway Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hedgehog Pathway Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hedgehog Pathway Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hedgehog Pathway Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hedgehog Pathway Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hedgehog Pathway Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hedgehog Pathway Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hedgehog Pathway Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hedgehog Pathway Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hedgehog Pathway Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hedgehog Pathway Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hedgehog Pathway Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Hedgehog Pathway Inhibitors Product
Table 65. Pfizer Revenue in Hedgehog Pathway Inhibitors Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Hedgehog Pathway Inhibitors Product
Table 70. Novartis Revenue in Hedgehog Pathway Inhibitors Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Hedgehog Pathway Inhibitors Product
Table 75. Roche Revenue in Hedgehog Pathway Inhibitors Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Mayne Pharma Group Company Details
Table 78. Mayne Pharma Group Business Overview
Table 79. Mayne Pharma Group Hedgehog Pathway Inhibitors Product
Table 80. Mayne Pharma Group Revenue in Hedgehog Pathway Inhibitors Business (2016-2021) & (US$ Million)
Table 81. Mayne Pharma Group Recent Development
Table 82. PellePharm Company Details
Table 83. PellePharm Business Overview
Table 84. PellePharm Hedgehog Pathway Inhibitors Product
Table 85. PellePharm Revenue in Hedgehog Pathway Inhibitors Business (2016-2021) & (US$ Million)
Table 86. PellePharm Recent Development
Table 87. Sun Pharmaceutical Company Details
Table 88. Sun Pharmaceutical Business Overview
Table 89. Sun Pharmaceutical Hedgehog Pathway Inhibitors Product
Table 90. Sun Pharmaceutical Revenue in Hedgehog Pathway Inhibitors Business (2016-2021) & (US$ Million)
Table 91. Sun Pharmaceutical Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hedgehog Pathway Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Vismodegib Features
Figure 3. Erismodegib Features
Figure 4. Other Features
Figure 5. Global Hedgehog Pathway Inhibitors Market Share by Application: 2020 VS 2027
Figure 6. Basal Cell Carcinoma (BCC) Case Studies
Figure 7. Acute Lymphoblastic Leukemia (AML) Case Studies
Figure 8. Other Case Studies
Figure 9. Hedgehog Pathway Inhibitors Report Years Considered
Figure 10. Global Hedgehog Pathway Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hedgehog Pathway Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hedgehog Pathway Inhibitors Market Share by Regions: 2020 VS 2027
Figure 13. Global Hedgehog Pathway Inhibitors Market Share by Regions (2022-2027)
Figure 14. Global Hedgehog Pathway Inhibitors Market Share by Players in 2020
Figure 15. Global Top Hedgehog Pathway Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hedgehog Pathway Inhibitors as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hedgehog Pathway Inhibitors Revenue in 2020
Figure 17. Global Hedgehog Pathway Inhibitors Revenue Market Share by Type (2016-2021)
Figure 18. Global Hedgehog Pathway Inhibitors Revenue Market Share by Type (2022-2027)
Figure 19. North America Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hedgehog Pathway Inhibitors Market Share by Type (2016-2027)
Figure 21. North America Hedgehog Pathway Inhibitors Market Share by Application (2016-2027)
Figure 22. North America Hedgehog Pathway Inhibitors Market Share by Country (2016-2027)
Figure 23. United States Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hedgehog Pathway Inhibitors Market Share by Type (2016-2027)
Figure 27. Europe Hedgehog Pathway Inhibitors Market Share by Application (2016-2027)
Figure 28. Europe Hedgehog Pathway Inhibitors Market Share by Country (2016-2027)
Figure 29. Germany Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hedgehog Pathway Inhibitors Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hedgehog Pathway Inhibitors Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hedgehog Pathway Inhibitors Market Share by Region (2016-2027)
Figure 39. China Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hedgehog Pathway Inhibitors Market Share by Type (2016-2027)
Figure 47. Latin America Hedgehog Pathway Inhibitors Market Share by Application (2016-2027)
Figure 48. Latin America Hedgehog Pathway Inhibitors Market Share by Country (2016-2027)
Figure 49. Mexico Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hedgehog Pathway Inhibitors Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hedgehog Pathway Inhibitors Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hedgehog Pathway Inhibitors Market Share by Country (2016-2027)
Figure 55. Turkey Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hedgehog Pathway Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Hedgehog Pathway Inhibitors Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Hedgehog Pathway Inhibitors Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Hedgehog Pathway Inhibitors Business (2016-2021)
Figure 61. Mayne Pharma Group Revenue Growth Rate in Hedgehog Pathway Inhibitors Business (2016-2021)
Figure 62. PellePharm Revenue Growth Rate in Hedgehog Pathway Inhibitors Business (2016-2021)
Figure 63. Sun Pharmaceutical Revenue Growth Rate in Hedgehog Pathway Inhibitors Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Global JAK and PI3K Signaling Pathway Market Size, Status and Forecast 2021-2027
QFJ1-5814 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、JAK＆PI3Kシグナル伝達経路の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PI3K、ヤヌスキナーゼ療法（阻害剤）、PI3K療法（阻害剤）、JAK・PI3Kシグナル伝達バイオマーカー）、用途別市場...

世界のイソクエン酸デヒドロゲナーゼ阻害剤市場規模・現状・予測（2021年-2027年）

Global Isocitrate Dehydrogenase Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-4398 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、イソクエン酸デヒドロゲナーゼ阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IDH1変異髄質悪性腫瘍、IDH2変異髄質悪性腫瘍、その他）、用途別市場規模（DH阻害剤、FLT3阻害剤、ヘッジホッグ...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年）

Global Adrenal Corticosteroid Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3766 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、副腎皮質ホルモン阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オシロドロスタット、メチラポン）、用途別市場規模（病院、ホームケア、専門センター、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界のがんCDK阻害剤市場規模・現状・予測（2021年-2027年）

Global Cancer CDK Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3953 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、がんCDK阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIII）、用途別市場規模（医療機関、科学研究センター）、主要地域別市場規...

世界のB細胞リンパ腫2阻害剤市場規模・現状・予測（2021年-2027年）

Global B-cell lymphoma 2 Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5610 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、B細胞リンパ腫2阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、主要地域別市場規模（北米、アメ...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界の選択的セロトニン再取り込み阻害薬（SSRI）市場規模・現状・予測（2021年-2027年）

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2021-2027
QFJ1-6005 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シタロプラム（セレクサ）、エスシタロプラム（レクサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシ...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年） T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes. Market Analysis and Insights: Global T-cell Acute Lymphoblastic Leukemia Treatment Market The global T-cell Acute Lymphoblastic…
世界のJAK＆PI3Kシグナル伝達経路市場規模・現状・予測（2021年-2027年） Therapies related to the JAK and PI3K signaling pathways have the potential to target diseases such as cancer and inflammatory diseases, and no suitable drugs are currently available. Current therapies can reduce the burden of disease, but they cannot be cured. Significant progress has been made in …
世界の急性リンパ性/リンパ芽球性白血病（ALL）治療法市場規模・現状・予測（2021年-2027年） Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that quickly progresses and spreads across the body. ALL develops in bone marrow and quickly invades other parts of the body including the liver, spleen, lymph …
世界のイソクエン酸デヒドロゲナーゼ阻害剤市場規模・現状・予測（2021年-2027年） Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2. Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors includ…
世界のB細胞リンパ腫2阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. The symptoms of hematological malignancies are often mild…